Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $17.9100 (5.66%) ($17.0000 - $18.1000) on Thu. Mar. 26, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.61% (three month average) | RSI | 44 | Latest Price | $17.9100(5.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 3.7% a day on average for past five trading days. | Weekly Trend | HALO declines -4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(51%) IBB(50%) IWM(46%) ARKG(45%) XBI(45%) | Factors Impacting HALO price | HALO will decline at least -1.805% in a week (0% probabilities). VIXM(-33%) VXX(-16%) UUP(-13%) TBT(-0%) TLT(2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.805% (StdDev 3.61%) | Hourly BBV | 0 () | Intraday Trend | 5.4% | | | |
|
5 Day Moving Average | $16.77(6.8%) | 10 Day Moving Average | $16.07(11.45%) | 20 Day Moving Average | $17.55(2.05%) | To recent high | -18% | To recent low | 28.8% | Market Cap | $2.448b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |